Tech Company Financing Transactions
PathologyWatch Funding Round
PathologyWatch, operating out of Salt Lake City, secured $25 million in investment from Blackbrook Management, Blueprint Health and Ceros.
Transaction Overview
Company Name
Announced On
11/17/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Rock Creek Capital (Rick Stratford)
SpringTide Ventures (Austin Walters)
Proceeds Purpose
With the new funding, PathologyWatch will broaden its outreach to dermatologists and conduct further research into skincare diagnostics and AI -- allowing patients to receive faster diagnoses and more equitable access to dermatopathology services while enabling labs to work more efficiently and cost-effectively.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
166 East 5900 South B104
Salt Lake City, UT 84107
USA
Salt Lake City, UT 84107
USA
Phone
Website
Email Address
Overview
PathologyWatch is working with clinical dermatology practices like yours to manage your pathology workflow using a digital model. This helps to improve the quality of patient care, reduce costs, and open up new potential steams of revenue for clinics and hospitals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Lambert
Chief Medical Officer
Gregory Osmond
VP - Bus. Development
Michael Torno
Browse more venture capital transactions:
Prev: 11/17/2021: Dubit venture capital transaction
Next: 11/17/2021: Goody Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs